Novel Pseudomonas aeruginosa scoring system to guide empiric anti-pseudomonal therapy in COPD patients with community-acquired pneumònia

S. Pascual Guardia (Barcelona, Spain), J. Marin Corral (Barcelona, Spain), F. Amati (Milan, Italy), S. Aliberti (Milan, Italy), J. Gea (Barcelona, Spain), N. J.Soni (San Antonio, United States of America), A. Rodríguez (Tarragona, Spain), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A Coruña, Spain), M. Kolditz (Dresden, Germany), A. Antonio (San Antonio, United States of America), M. Restrepo (San Antonio, United States of America)

Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Session: Cardiovascular and pulmonary complications of respiratory infections
Session type: E-poster session
Number: 1788
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Pascual Guardia (Barcelona, Spain), J. Marin Corral (Barcelona, Spain), F. Amati (Milan, Italy), S. Aliberti (Milan, Italy), J. Gea (Barcelona, Spain), N. J.Soni (San Antonio, United States of America), A. Rodríguez (Tarragona, Spain), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A Coruña, Spain), M. Kolditz (Dresden, Germany), A. Antonio (San Antonio, United States of America), M. Restrepo (San Antonio, United States of America). Novel Pseudomonas aeruginosa scoring system to guide empiric anti-pseudomonal therapy in COPD patients with community-acquired pneumònia. 1788

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: